Serious hematological diseases in the Pediatric Intensive Care Unit of Pinar del Río
Keywords:
HEMATOLOGIC DISEASES/classification, Etiology, CHILD, CRITICAL CARE.Abstract
Introduction: patients with hematological diseases admitted in intensive care units have special characteristics because they have complex diseases requiring a multidisciplinary approach. Intensive care has contributed to the improvement of their survival by the use of new diagnostic and therapeutic strategies.
Objective: to elaborate a set of rules to perform the diagnostic and therapeutic procedures on the severe types of hematological diseases.
Method: a cross-sectional and descriptive research was carried out comprising the patients suffering from hematological diseases treated in the intensive care service at Pepe Portilla Provincial Pediatric Teaching Hospital, Pinar del Río between the years 2011 to 2015. The information was processed using the method of descriptive statistics with a computer program and processed using the statistical software EPINFO.
Results: 64% of the patients were male, the group of ages from 5-10 years old predominated, acute lymphoblastic leukemia was the most frequent disease and myeloblastic showed the highest mortality rate. Septic shock (25%), acute respiratory failure (19.4%), and respiratory distress (16.6%) were the main complications presented in this service; neutropenia was the most influential factor of the syndrome due to the systemic inflammatory response.
Conclusion: malignant diseases sometimes present a serious evolution, requiring admission to intensive care, leukemias are well-known within them.
Downloads
References
1. Ferreres Franco J. Predicción de la Mortalidad de pacientes con enfermedad hematológica que requieren ingreso en la Unidad de cuidados intensivos. [Tesis Doctorado]. España: Universidad Valencia, 2012. Disponible en: http://roderic.uv.es/bitstream/handle/10550/28765/Tesis%20Hemato%20Jose_T%Edtulos%20Nov2012%2017%20x%2024.pdf?sequence=1.
2. Rodríguez Jáuregui EK, Blanco Montero A, Iglesias Leboreiro J, Bernárdez Zapata I, Rendón Macíasa ME. Condición Clínica a la hospitalización y relación con el ingreso a terapia intensiva pediátrica. Rev Med Inst Mex Seguro Soc [Internet]. 2014 [citado 20 Ene 2017]. ; 52(3): [aprox. 9 p.].Disponible en: http://www.medigraphic.com/pdfs/imss/im-2014/im143l.pdf.
3. Ferra CH, Lacoma A, Garcıa O, Marcos P,Domınguez J, Ribera JM. Relación entre los valores séricos de procalcitonina y las complicaciones y supervivencia de pacientes con hemopatias malignas ingresados en una Unidad de Vigilancia Intensiva. Med Clin (Barc) [Internet]. 2012[citado 11 Dic 2016];138(9): [aprox. 7 p.].Disponible en:
http://www.sciencedirect.com/science/article/pii/S0025775311011687.
4. Morales Peralta A, Covarrubias Espinoza G, Rendón García H. Supervivencia en Niños con Leucemia Aguda Linfoblástica Tratados en Base a Factores de Riesgo Inmunomoleculares. Bol Clin Hosp Infant Edo Son [Internet]. 2014 [citado 2016 dic 11]; ;31(2); [aprox. 6 p.].Disponible en:
http://www.medigraphic.com/pdfs/bolclinhosinfson/bis-2014/bis142e.pdf.
5. Ferrà CH, María Ribera J. Pronóstico de los pacientes con enfermedad hematológica ingresados en una Unidad de Cuidados Intensivos. Med Clin (Barc). 2012 [citado 2017 Ene 11]; 139(14): [aprox. 6 p.].Disponible en: http://www.elsevier.es/es-revista-medicina-clinica-2-articulo-pronostico-los-pacientes-con-enfermedad-S002577531200601X
6. Last Medical Review. Cuáles son los factores de riesgo de la leucemia mieloide aguda? Last Revised [Internet] 2015 [citado 2017 Ene 11]. Disponible en: https://www.cancer.org/es/cancer/leucemia-mieloide-aguda/causas-riesgos-prevencion/factores-de-riesgo.html
7. Pino Blanco D, Macías Abraham C, Lahera Sánchez T, Marsán Suárez V, Sánchez Segura MC, del Valle Pérez Lázaro O, et al. Caracterización inmunofenotípica de pacientes con leucemia mieloide aguda [Internet]. 2014 Mar [citado 2016 Nov 09];30(1): [aprox. 10 p.]. Disponible en:
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892014000100005&lng=es
8. Izaguirre González A, Sánchez Sierra LE, Cerrato Castro A, Flores Irías J, Peña A. Síndrome Hemofagocítico Reactivo en Lactante Mayor. Reporte de Caso. ARCHIVOS DE MEDICINA [Internet]. 2016 [citado 2017 Feb 12]; 12(3): [aprox. 9 p.]. Disponible en: http://www.archivosdemedicina.com/medicina-de-familia/sndrome-hemofagoctico-reactivo-en-lactante-mayor-reporte-de-caso.pdf.
9. Ortega Bermúdez Y. Calidad de Vida relacionada con la Salud en pacientes con drepanocitosis. Revista 16 de Abril [Internet]. 2013 Dic [citado 2017 feb 12];253(1):[aprox. 5 p.]. Disponible en:
http://www.16deabril.sld.cu/rev/253/ao01
10. Villalba Toquica CP, Martínez Silva PA. Caracterización clínico-epidemiológica de los pacientes pediátricos con leucemias agudas en la Clínica Universitaria Colombia. Serie de casos 2011-2014. Pediatr [Internet]. 2016 [citado 2017 feb 10]; 49(1): [aprox. 7 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0120491216000148
11. Madero L, Lassaletta Á, Sevilla J. Hematología y Oncología Pediátricas.3a.ed. Madrid; 2015.
12. Hernández Padrón C, Svarch Guerchicoff E, Agramonte Llanes O, Machín García S, Menéndez Veitia A. Drepanocitosis en Cuba: 30 años de investigación, diagnóstico y tratamiento Rev Hematol Mex [Internet]. 2015 [citado 10 Feb 2017];16(supl. 1): [aprox. 13 p. ]. Disponible en: http://www.amehac.org/wp-content/uploads/2013/05/Rev-Hematol-Mex-201314-Suppl-1.pdf
13. Arias M, Godoy J, Maya L, Vásquez P, Suárez A. Caracterización de los pacientes de una Unidad de Cuidado Intensivo Pediátrico exclusivamente oncológica. Revista Colombiana de Cancerología [Internet].2015 Abr [citado 2015 ene 10]; 19(2): [aprox 10 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0123901515000268
14. López Iniesta S, Payá I, Mira G, Perceval J. Fiebre en el paciente oncológico. Módulo Oncología Pediátrica. [Internet]. 2015 Disponible en: http://www.serviciopediatria.com/wp-content/uploads/2015/06/Protocolo-FIEBRE-EN-EL-PACIENTE-ONCOLOGICO-SP-HGUA-2015.pdf
15. Cuba. Anuario Estadístico de Salud. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadística de Salud. [Internet]. La Habana; 2016. Disponible en: http://files.sld.cu/dne/files/2016/04/Anuario_2015_electronico-1.pdf.
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
